Akari Therapeutics, Plc (AKTX) Stock Price

10.96 ▼ -0.51 (-4.45%)
Open: 11.32 Vol: 128.53K Day's range: 10.75 - 12.04 Sep 08, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 11.30▼ 11.30▼ 11.28▼ 10.76▲ 9.70▲
MA10 11.39▼ 11.41▼ 11.37▼ 10.09▲ 9.70▲
MA20 11.38▼ 11.11▲ 10.81▲ 8.84▲ 10.37▲
MA50 10.68▲ 10.23▲ 9.61▲ 9.61▲ 12.97▼
MA100 9.70▲ 8.88▲ 8.62▲ 9.54▲ 31.41▼
MA200 8.62▲ 9.50▲ 9.99▲ 9.86▲ 99.90▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.071▼ -0.063▼ -0.036▼ 0.407▲ 0.485▲
RSI 51.364▲ 55.487▲ 58.180▲ 62.295▲ 49.848▼
STOCH 22.422     31.409     59.356     78.029     30.093    
WILL %R -87.770▼ -53.982     -33.702     -23.632▲ -52.813    
CCI -75.140     -32.227     20.303     105.642▲ 34.363    
Latest Filters Detected On AKTX
CDL $AKTX Harami Candlestick Pattern Detected Set Alert
Akari Therapeutics, Plc News
Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums
Tuesday, September 08, 2026 06:15 AM
Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September CEO Abizer Gaslightwala to deliver keynote ...
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
Thursday, August 27, 2026 06:01 AM
Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- , Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel ...
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
Tuesday, August 18, 2026 01:53 AM
AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari’s novel PH1 RNA spliceosome-modulating ...
AKTX historical stock data
date open high low close volume
08/09/26 11.32 12.04 10.75 10.96 128,525
04/09/26 10.41 11.82 10.1703 11.47 108,162
03/09/26 10.00 11.40 9.65 10.84 61,947
02/09/26 10.09 10.40 9.60 10.15 46,491
01/09/26 10.44 10.50 9.44 10.37 174,774
31/08/26 10.53 11.40 9.75 10.43 80,615
28/08/26 8.93 11.08 8.80 10.70 168,078
27/08/26 9.60 9.60 8.75 9.01 53,890
26/08/26 8.10 9.9599 7.95 9.10 254,610
25/08/26 7.97 8.10 7.6901 7.87 30,406
Quote Details
52wk Low:3.015
52wk High:49.60
Vol:128.53K
Avg Vol(3m):1M
1Y Chng:-75.32%
1M Chng:+30.01%
Add to Watch List
More Information
Index US Composite
Market Cap. 22.33M